News | December 13, 2006

Dying German Patient Receives TAH-t Today

Physicians at the Center of Cardiac Surgery Erlangen-Nuremberg at Friedrich Alexander Hospital have initiated a new training and certification program for implanting the CardioWest temporary Total Artificial Heart (TAH-t). Led by Prof. Michael Weyand, M.D., cardiac surgeon, Dr. Tandler, and members of the heart transplant team at the center, the training is a four-part certification process that includes the proctored implant of the center's first CardioWest TAH-t today, Dec. 14, 2006.

Whereas some hospitals wait months to find an appropriate patient for the first proctored implant of the TAH-t, at Friedrich Alexander Hospital that patient is already there. This patient is unlikely to survive more than a couple of weeks without a TAH-t implant or a human heart transplant.

Speaking from Monday's training, Dr. Tandler said, "We already have an excellent candidate for the artificial heart.

“We are excited to now have a device we can use to help him survive to transplant," said Dr. Tandler. The surgery will be performed by Dr. Tandler and proctored by cardiovascular surgeon Latif Arusoglu, M.D., who has performed over 100 TAH-t implants at the Heart and Diabetes Center NRW in Bad Oeynhausen, Germany.

The CardioWest(TM) TAH-t is used as a "bridge to transplant" for transplant eligible patients who: 1) have both sides of their heart failing, 2) do not respond to other treatments, and 3) are at imminent risk of death.

Related Content

St. Jude Medical, HeartMate 3 LVAS, MOMENTUM 3 IDE study results, AHA Scientific Sessions 2016
News | Ventricular Assist Devices (VAD)| December 08, 2016
St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-breaking clinical trial...
SynCardia, Chapter 11 reorganization, sale, Total Artificial Heart
News | Artificial Heart| September 13, 2016
August 29, 2016 — SynCardia Systems, manufacturer of the...
Carmat, bioprosthetic artificial heart, PIVOTAL study, first implantation, heart failure
News | Artificial Heart| September 09, 2016
Carmat announced that the first implantation of its bioprosthetic artificial heart within the framework of the PIVOTAL...
SynCardia acquired, Versa Capital Management, chapter 11
News | Business| July 07, 2016
SynCardia Systems Inc. announced that it has entered into an asset purchase agreement (“APA”) with an affiliate of...
SynCardia Total Artificial Heart, TAH-t, documentary, Retro Reports, The New York Times
News | Artificial Heart| March 24, 2016
March 24, 2016 — A new documentary produced by Retro Report for The New York Times looks at the history and
Bryan Tyo, Baylor University Medical Center, bridge to transplant, Total Artificial Heart
News | Artificial Heart| March 18, 2016
A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient...
HeartWare, ENDURANCE2 trial, destination therapy, HVAS, HeartWare Ventricular Assist System
News | Ventricular Assist Devices (VAD)| August 11, 2015
HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical trial has been...
News | January 30, 2015
SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the...
syncardia, artificial heart

SynCardia Total Artificial Heart

News | November 24, 2014
A 19-year-old woman was successfully implanted with the SynCardia temporary Total Artificial Heart and bridged to a...
Overlay Init